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Abstract  1 
Immobilization of bioactive peptide sequences on CoCr surfaces is an effective route to improve 2 
endothelialization, which is of great interest for cardiovascular stents. In this work, we explored 3 
the effect of physical and covalent immoblization of RGDS, YIGSR and their equimolar 4 
combination peptides on endothelial cells (EC) and smooth muscle cell (SMC) adhesion and on 5 
thrombogenicity. We extensively investigated using RT-qPCR, the expression by ECs cultured 6 
on functionalised CoCr surfaces of different genes. Genes relevant for adhesion (ICAM-1 and 7 
VCAM-1), vascularization (VEGFA, VEGFR-1 and VEGFR-2) and anti-thrombogenicity (tPA 8 
and eNOS) were over-expressed in the ECs grown to covalently functionalized CoCr surfaces 9 
compared physisorbed and control surfaces. Pro-thrombogenic genes expression (PAI-1 and 10 
vWF) decreased over time. Cell co-cultives of ECs/SMCs found that functionalization increased 11 
the amount of adhered ECs onto modified surfaces compared to plain CoCr, independently of 12 
the used peptide and the strategy of immobilization. SMCs adhered less compared to ECs in all 13 
surfaces. All studied peptides showed a lower platelet cell adhesion compared to TCPS. 14 
Covalent functionalization of CoCr surfaces with an equimolar combination of RGDS and 15 
YIGSR represented prevailing strategy to enhance the early stages of ECs adhesion and 16 
proliferation, while preventing SMCs and platelet adhesion.   17 
Key Words 18 
Functionalization; CoCr alloy; gene expression; platelet adhesion; cell co-culture  19 
  20 
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Short title: CELL ADHESIVE PEPTIDES FUNCTIONALIZED ON CoCr ALLOY  1 
 2 
INTRODUCTION  3 
Atherosclerosis, the hardening of arteries due to build-up of lipoproteins, is one of the leading 4 
causes of death worldwide.1–3 One of the most common treatments for vessel occlusion due to 5 
atherosclerotic lesion formation is stent implantation where the stent is expanded in the 6 
narrowed artery recovering blood flow. While stenting has become a widely used procedure, it 7 
is not without complications.  8 
In-stent restenosis4 and late stent thrombosis5 are the main drawbacks of actual bare metal stents 9 
(BMS)
6
 and drug-eluting stents (DES),
4
 respectively. In-stent restenosis is due to the body’s 10 
own wound healing response to the mechanical injury associated with stent implantation7 where 11 
increased proliferation of smooth muscle cells (SMCs) leads to renarrowing of the arteries.
 8
 12 
Late stent thrombosis might be related to a delay in re-endothelialization following stenting, 13 
which has been shown in pathology studies.9 A stent surface rapid endothelialization minimizes 14 
the failures associated with blood clotting and platelet activation
10
 and is expected to reduce in-15 
stent restenosis. The rate and quality of endothelialization of a stent depend on interactions 16 
between endothelial cells (ECs) with the biomaterial surface.  17 
Material surface properties can be modified by physicochemical modification and/or 18 
biofunctionalization to promote EC adhesion and inhibit thrombosis by influencing protein 19 
adsorption and subsequent cell behavior.11,12 But, in the recent years, there is a growing interest 20 
in the immobilization of bioactive molecules on the surface of biomaterial implants through 21 
covalent bonding.
13,14
 Covalent functionalization is based on the formation of a covalent linkage 22 
between functional entities and the material surface. The advantages of the process includes  23 
control of molecular orientation, minimization of non-specific interactions, and greater stability 24 
of the functional surface by preventing dissolution, desorption, and degradation of molecules.15 25 
However, the optimal sequences and their combinations remain to be elucidated.  26 
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The inner arterial wall of the entire vascular system consist of a continuous single layer of ECs 1 
which separates blood from the vessel wall.16 The endothelium regulates the transfer of 2 
molecules, such as lipoproteins, between the blood and vessel wall  and acts as a semipermeable 3 
barrier.
17,18
 In addition to serving as a physical barrier, ECs also control many important 4 
functions in vascular homeostasis including vascular tone, inflammation, and lipid and tissue-5 
fluid homeostasis, and has antithrombotic properties.18 The antithrombotic and anticoagulant 6 
balance is maintained through processes involving nitric oxide production, prostacyclin, tissue 7 
plasminogen activator, thrombomodulin, heparin-like molecules, tissue-factor pathway inhibitor 8 
and many other molecules.9 Designed biomaterial should stimulate ECs adhesion and migration 9 
and prevent SMCs adhesion and proliferation in order to obtain a functional artery.  10 
Based on previous results of functionalized CoCr alloy surfaces with RGDS, REDV and YIGSR 11 
peptides, we find that peptides immobilization, specially the combination of RGDS and YIGSR, 12 
represent a good strategy to enhance initial EC adhesion and migration.
19
 The bioactivity of 13 
these peptides has been thoroughly demonstrated by scrambling their sequences.20–22 Now we 14 
would like to go a step further by studying the effect of functionalized CoCr surfaces on gene 15 
expression of EC. Specifically, expression profiles of nine gene markers, related with four 16 
different functions of EC: adhesion (ICAM-1 and VCAM-1), vascularization (VEGFA, 17 
VEGFR-1 and VEGFR-2), pro thrombogenic (PAI-1 and vWF) and anti-thrombogenic genes 18 
(eNOS and tPA) were analyzed by real time quantitative polymerase chain reaction (RT-qPCR). 19 
Also, we have evaluated thrombogenicity of the peptides by quantifying platelet adhesion and 20 
aggregation under defined shear stress conditions.
23
   21 
Moreover, a co-culture system has been performed by plating EC and SMC together in tissue 22 
culture to evaluate the rapid competitive adhesion, proliferation and migration of ECs and 23 
SMCs to identify the aspects of the modified CoCr surfaces, which favor re-endothelialization 24 
while alongside inhibiting the SMCs proliferation and platelet adhesion.  25 
 26 
MATERIAL AND METHODS 27 
Metallic surface 28 
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Comercial CoCr alloy discs (8.5 mm in diameter, 2-3 mm thick) were obtained from CoCr alloy 1 
(ASTM F90) bars (Technalloy S.A., Barcelona, Spain). Samples were polished to achieve 2 
mirror-like, smooth surfaces by grinding with abrasive SiC papers (Neuertek S.A., Eibar and 3 
Beortek S.A., Asua-Erandio, Spain) of decreasing grit size (P600, P800 and P1200), followed 4 
by polishing with suspension of alumina particles (1 µm and 0,05 µm). Prior to 5 
biofuncionalization, all samples were ultrasonically rinsed with ethanol, distilled water and 6 
acetone and stored dried.  7 
 8 
Solid-phase peptide synthesis 9 
The linear peptides MPA-(Ahx)3-Arg-Gly-Asp-Ser-OH (RGDS) and MPA-(Ahx)3-Tyr-Ile-10 
Gly-Ser-Arg-OH (YIGSR) (Ahx: aminohexanoic acid; MPA: 3-mercaptopropionic acid) were 11 
manually synthesized by solid-phase following the Fmoc/tBu strategy and using CTC resin (200 12 
mg, 1.0 mmol/g) as previously reported.
24
 The purified peptides were characterized by 13 
analytical HPLC analysis and MALDI-TOF. All chemicals required for the synthesis, including 14 
resins, Fmoc-L-amino acids and coupling reagents, were obtained from Iris Biotech GmbH 15 
(Marktredwitz, Germany) and Sigma-Aldrich (St Louis, MO, USA).  16 
 17 
Cell culture  18 
Human umbilical vein endothelial cells (HUVECs) were cultured in EC basal medium (EBM®) 19 
supplemented with EGM-2 BulletKit and 5% (v/v) fetal bovine serum (FBS).Human vascular 20 
coronary artery smooth muscle cells (CASMCs) were grown in SMC basal medium (SmBm®) 21 
supplemented with SmGM-2 BulletKit and 5% (v/v) FBS. All cells, mediums and supplements 22 
were purchased from Lonza (Basel, Switzerland). Cells were maintained at 37°C, in a humified 23 
atmosphere containing 5% (v/v) CO2 and culture medium was renewed every 2 days. Cell 24 
culture was performed in Nunc cell flasks (Thermo Scientific, Denmark) pre-coated with 25 
1µg/ml of human plasma fibronectin (Sigma-Aldrich) in PBS.  HUVECs at passages 4 to 83,13 26 
and CASMCs at passages 4 to 6
25,26
 were used in all the experiments.  27 
 28 
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Biofucntionalization of CoCr surfaces 1 
Prior to silanization, CoCr samples were activated by alkaline etching with 5M NaOH for 2 2 
hours and after, samples were throughly cleaned by immersion in distilled water for 30 min 3 
twice. After activation the samples were introduced in a N2-saturated glass vessel and immersed 4 
for 1 h at 90°C in a solution containing 0,5 M 3-chloropropyltriethoxysilane (CPTES) and 0,05 5 
M N,N-diisopropylethylamine (DIEA) in anhydrous toluene (Sigma-Aldrich) under nitrogen 6 
atmosphere. Next, samples were ultrasonicated successively in cyclohexane, isopropanol, 7 
distilled water and acetone, and finally dried with N2 gas.  8 
Biomolecules were immobilized on the CoCr surfaces by two different methods: (1) physical 9 
adsorption on plain CrCo samples (samples were coded as CT+peptide); and (2) covalent 10 
immobilization through silanization process of the CoCr activated surfaces with CPTES 11 
(samples coded as NA-CP+peptide). 12 
The RGDS, YIGSR peptides and their combinantion (1:1) were dissolved in a solution of 13 
phosphate buffered saline (PBS) adjusted with Na2CO3 to obtain a pH of 13.0 at a concentration 14 
of 100 µM. 100 µl of peptide solutions were deposited on the CPTES-grafted surfaces overnight 15 
at room temperature (RT). To adsorb physically the peptide on non-silanized samples, the same 16 
conditions were used but using PBS at pH 7.4 instead. Control samples were only treated with 17 
buffer. After peptide incubation, samples were gently washed three times with distilled water 18 
and dried with nitrogen.  19 
The biofunctionalized samples, and their controls, are codified as follows:  20 
CT: Non-treated smooth CoCr surface.  21 
CT-RGDS: CoCr surface coated with 100 µM of RGDS peptide.  22 
CT-YIGSR: CoCr surface coated with 100 µM of YIGSR peptide.  23 
CT-RGDS+YIGSR: CoCr surface coated with 100 µM of RGDS+YIGSR combined peptides. 24 
NA-CP-RGDS: CoCr activated with NaOH, silanized with CPTES and coated with 100 µM of 25 
RGDS peptide.  26 
NA-CP-YIGSR: CoCr activated with NaOH, silanized with CPTES and coated with 100 µM of 27 
YIGSR peptide.  28 
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NA-CP-RGDS+YIGSR: CoCr activated with NaOH, silanized with CPTES and coated with 1 
100 µM of RGDS+YIGSR combined peptides.  2 
Prior to cell adhesion assays, functionalized samples were blocked for 1 h at 37 º C with 5% 3 
(w/v) bovine serum albumin (BSA) in PBS in order to reduce non-specific interactions of the 4 
cells with the surface.24,27–29  5 
 6 
Quantitative real-time polymerase chain reaction 7 
Expression of adhesion (ICAM-1, VCAM-1), vascularization (VEGFA, VEGFR-1, VEGFR-2), 8 
pro-thrombogenic (vWF, PAI-1) and anti-thrombogenic (tPA, eNOS) genes (Table 1) in 9 
HUVECs on modified CoCr surfaces was determined through RT-qPCR assay after 24 h, 48 h 10 
and 72 h as previously described.30  11 
At each culture time, total RNA was extracted using RNeasy® Mini Kit (Qiagen, Hilden, 12 
Germany) and quantified using a NanoDrop ND-1000 spectrophotometer (NanoDrop 13 
Technologies, Montchanin, DE, USA). One hundred nanograms were retrotranscribed to cDNA 14 
products which were further diluted and used as RT-qPCR templates (Quantitect Reverse 15 
Transcription Kit, Qiagen). The resulting cDNA is then amplified using the QuantiTect SYBR 16 
Green RT-qPCR Kit (Qiagen) in an ABIPrism 7700 machine (Applied Biosystems, Foster City, 17 
CA, USA). Specifity of each RT-qPCR reaction was determined by melting curve analysis and 18 
by resolving the RT-qPCR products on 2% agarose gels. The expression of all studied genes 19 
was normalized by the expression levels of β-actin. Moreover, fold changes were related to CT 20 
at 24 h of culture.  21 
 22 
Platelet adhesion  23 
Platelet activation and adhesion on the peptides were evaluated by exposing human blood to 24 
physiological arterial shear stress. Peptides were physisorbed into a commercially avalaible 25 
cone and plate-shearing device (Diamed Impact-R; Biorad Diamed GmbH, Cressier, 26 
Switzerland). The Impact-R [Cone and plate(let) analyzer] is designed to evaluate platelet 27 
function under flow conditions.31 Samples of citrate phosphate dextrose (CPD) anti-coagulated 28 
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whole blood (130 µl) were placed on polystyrene wells and subjected to flow at 1800 s-1 for 2 1 
min using a specially designed conical disk. Wells were then thoroughly washed with PBS, 2 
stained with May-Gruenwald stain and analyzed by the Impact-R analyzer system connected to 3 
a microscope. Platelet adhesion was determined by measuring the percentage of the well surface 4 
covered with platelets and the average size of the aggregates.  5 
 6 
Immunofluorescence analysis of HUVECs and CASMCs co-culture 7 
The HUVECs and CASMCs were separately grown until confluence. Then, a direct cell contact 8 
co-culture was performed by seeding onto the modified CoCr surfaces 10
4
 cells/well
 
HUVECs 9 
and 10
4
 cells/well CASMCs in mixed EBM® and SmBm® (1:1) free-serum medium. After 24 10 
h, the serum-free medium was changed by complete EBM® and SmBm® (1:1) medium until 11 
analysis.  To discriminate cells by immunofluoscence, two specific cell-markers were used: 12 
PECAM-1 platelet endothelial cell adhesion molecule (CD31, Sigma Aldrich) for staining 13 
HUVECs and α-SMA α-smooth muscle actin (A5228, Sigma Aldrich) for staining CASMCs. 14 
Cells were fixed in a mixture of ethanol-acetone (50:50, v/v)
32
 for 30 min, permeabilized with 15 
0.05% (v/v) Triton X-100 in PBS for 20 min and blocked with 1% BSA (w/v) in PBS for 30 16 
min. HUVECs and SMCs were stained by incubating first with the primary antibodies mouse 17 
anti-PECAM-1 (1:100, in blocking solution) and rabbit anti-α-SMA (1:100 in blocking 18 
solution) for 1 h. Finally cells were stained by incubation with the secondary antibodies Alexa 19 
Fluor 488 chicken anti-rabbit (Sigma Aldrich) and Alexa Fluor 568 goat anti-mouse (Sigma 20 
Aldrich), during 1 h in the dark. Nuclei were counterstained with DAPI (1:1000, in PBS) for 10 21 
min in the dark. Between all steps, samples were rinsed twice with PBS for 5 min. CoCr disks 22 
were mounted and examined under a fluorescent inverted microscope (AF6500 widefield, Leica 23 
Microsystems, Germany) where images through stitching method were taken. Cell number and 24 
morphology were studied by ImageJ-FIJI software (NIH, USA). 25 
 26 
Statistical analysis 27 
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All the experiments were triplicated for each condition and repeated at least in two independent 1 
experiments. Statistical comparison of values was based on ANOVA using Tukey's test for pair-2 
wise comparison with p < 0.05. Differences were also analyzed by non-parametric Kruskal-3 
Wallis test. Values of all graphs are reported as mean ± standard deviation. Statistical analysis 4 
was performed using Minitab software (Minitab Inc., USA).  5 
 6 
RESULTS 7 
Cell adhesion gene expression 8 
The expression of genes related to cell adhesion (ICAM-1 and VCAM-1) was analysed at 24, 48 9 
and 72 h on the different functionalized CoCr surfaces by real time – qPCR (Fig. 1). ICAM-1 10 
gene expression was enhanced in HUVEC cultured on silanized CoCr surfaces, Na-CP series, 11 
after 48 h and even more upregulated after 72 h. Nonetheless, physisorbed series only presented 12 
a slightly increase of ICAM-1 expression after 48 and 72 h compared to plain CoCr, CT. From 13 
all tested surfaces NA-CP-RGDS+YIGSR was the functionalized CoCr substrate with a higher 14 
expression of ICAM-1 after 48 and 72 h. VCAM-1 gene expression showed an upregulation of 15 
its expression after 48 h specially for silanized series, whereas it was significally decreased after 16 
72 h for all tested surfaces [Fig. 1(b)]. 17 
 18 
Vascularization gene expression 19 
It was investigated the effect of immobilization of adhesive molecules onto CoCr, by 20 
physisorption or covalent binding, on the activation of HUVECs gene expression levels for 21 
vascularization through the analysis of VEGFA, VEGFR-1 and VEGFR-2 gene expression (Fig. 22 
2). The gene expression of VEGFA and VEGFR-2 was negligible for all surfaces at 24 and 48 23 
h, although it increased considerably after 72 h for all surfaces. An upregulated expression of 24 
VEGFR-2 was statistically significant for NA-CP-RGDS and NA-CP-RGDS+YIGSR series 25 
compared to CT. Concerning VEGFR-1, the gene expression was downregulated in all samples 26 
during time. In fact, at 24 h and 72 h no differences in expression levels were detected between 27 
the different surface treatments. Noteworthy, at 48 h CT-RGDS and NA-CP-RGDS+YIGSR 28 
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samples showed higher levels of VEGFR -1 gene expression compared to CT and CT-YIGSR, 1 
CT-RGDS+YIGSR, NA-CP-RGDS and NA-CP-YIGSR samples.  2 
 3 
Thrombogenicity gene expression  4 
Figures 3 and 4 show the expression of anti-thrombogenic and pro-thrombogenic genes, 5 
respectively, in HUVECs cultured onto physisorbed or functionalized CoCr surfaces. RT-qPCR 6 
measurements revealed that at lower times of cell culture, 24 h, the expression of eNOS 7 
antithrombogenic gene was lower than CT for all tested surfaces; whereas after 48 h the eNOS 8 
gene expression of functionalized surfaces was higher compared to CT but no statistically 9 
significant differences were detected between physisorbed and silanized samples. Finally, at 72 10 
h, the expression level of eNOS was statistically significant higher for silanized surfaces 11 
compared to physisorbed (i.e. CT-RGDS, CT-YIGSR and CT-RGDS+YIGSR) and CT surfaces. 12 
NA-CP-RGDS+YIGSR was the surface with a higher eNOS gene expression at 72 h. tPA gene 13 
expression [Fig. 3(b)] was upregulated after 72 h specially on CT-RGDS, CT-.RGDS+YIGSR 14 
and NA-CP-RGDS+YIGSR compared to control and CT-RGDS, NA-CP-RGDS and NA-CP-15 
YIGSR.  16 
The expression levels of pro-thrombogenic gene PAI-1 [Fig. 4(a)] reached the maximum 17 
expression after 48 h on NA-CP-YIGSR and NA-CP-RGDS+YIGSR but CT and CT-RGDS 18 
and CT-YIGSR showed a considerably decrease. Nevertheless, after 72 h the expression level of 19 
PAI-1 for all surfaces was significantly reduced. The vWF gene expression was downregulated 20 
over time [Fig. 4(b)]. While at 24 h all treated surfaces had lower levels of gene expression 21 
compared to CT, after 48 h the levels were slightly higher for all surfaces. Finally, after 72 h 22 
only NA-CP-RGDS+YIGSR presented higher values compared to CT.  23 
 24 
Platelet adhesion  25 
Figure 5(a) shows the percentage of surface covered by platelets and Figure 5(b) the platelets 26 
aggregate size onto TCPS coated with RGDS, YIGSR and RGDS+YIGSR under flow 27 
conditions to determine the potential anti-thrombogenicity of peptides. In general, TCPS coated 28 
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with peptides lead to a decrease of covered area by platelets and a reduction of the platelet 1 
aggregate size compared to non-coated TCPS. In particular, RGDS coating was the condition 2 
with a lower platelet adhesion compared to YIGSR and RGDS+YIGSR. Moreover, RGDS and 3 
RGDS+YIGSR were the peptide coatings with a lower size of platelet aggregates compared to 4 
YIGSR.       5 
 6 
HUVEC and CASMCs co-culture 7 
Figures 6 and 7 display the fluorescence images and the quantification of adhered HUVECs and 8 
SMCs in co-culture after 24h and 48 h onto CT physisorbed and NA silanized CoCr surfaces 9 
with RGDS, YIGSR and their equimolar combination. HUVECs and SMCs showed a capillary-10 
like morphology after 24 h as seen in Figure 6(a), specially for surfaces functionalized with 11 
YIGSR peptide and the equimolar combination of RGDS and YIGSR. The amount of HUVECs 12 
increased for all the treated surfaces after 48 h compared to 24 h of cell co-culture and 13 
compared to TCPS while SMCs underwent to lower proliferation after 48 h compared to 24 h. It 14 
was also observed an influence of the biomolecules coating since NA-CP-RGDS and NA-CP-15 
RGDS+YIGSR increased the quantity of adhered HUVEC cells after 24 h (Figure 7). Similarly, 16 
after 48 h CT-YIGSR and NA-CP-RGDS+YIGSR coated surfaces showed higher cell number 17 
compared to the other functionalized surfaces.  18 
 19 
DISCUSSION 20 
In this study, surface modified CoCr alloy substrates for cardiovascular applications were 21 
functionalized with RGDS, YIGSR peptides and their equimolar combination by physisorption 22 
and covalent binding via silanization using CPTES as coupling agent. Then, the behavior of 23 
HUVECs cultured onto the different surface finish was evaluated through adhesion, 24 
vascularization, pro-thrombogenic and anti-thrombogenic gene expression.  25 
Under normal physiological circumstances, ECs play a major role in preventing blood cells 26 
from adhering to the vasculature and subsequent coagulation.
9
 After stent implantation, 27 
interaction of ECs and biomaterial is a crucial step for implant endothelialization. Based on 28 
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 13 
preliminary results, we found that functionalization of peptides (e.g. RGDS, REDV and 1 
YIGSR) onto CoCr surfaces is a promising strategy to overcome this issue.19 There, we 2 
observed that combination of RGDS and YIGSR stimulated the adhesion of ECs. In addition to 3 
cell adhesion onto biomaterial, the cellular crosstalk through endothelial cell adhesion 4 
molecules such as VCAM-1 and ICAM-1 is also a critical step for endothelial integrity and 5 
functionality.13,33,34 In the present study, ICAM-1 gene expression increased with time reaching 6 
its highest values for NA-CP-RGDS+YIGSR followed by NA-CP-RGDS and NA-CP-YIGSR 7 
after 72 h. On the other hand, VCAM-1 gene expression was upregulated after 48 h especially 8 
for NA silanized series. These results suggest that RGDS, YIGSR and the equimolar 9 
combination RGDS and YIGSR immobilized by silanization onto CoCr surfaces, could increase 10 
endothelial activation (Table 2). In a previous study, differences in peptide densities between 11 
both silanization and physisorption strategies were described.
19
 Moreover, differences could not 12 
be attributed to silanes since no Si 2s was detected after peptides immobilization from X-ray 13 
photoelectron studies.19 And surface roughness increased from ≈6.3 nm for CT surfaces to 14 
≈16.0 nm for CoCr surfaces after NaOH etching. Thus, a higher quantity of immobilized 15 
peptide onto the surface by silanization compared to physisorption could be the reason for the 16 
increase of ICAM-1 and VCAM-1 gene expression.  17 
In addition to being indicators of an adequate endothelial integrity, cell adhesion molecules such 18 
as VCAM and ICAM regulate anti-thrombogenic events.
35,36
 Their expression in ECs is mainly 19 
regulated by VEGF, a potent angiogenic growth factor secreted by the ECs themselves. The 20 
main activities that VEGF regulates are endothelial cell survival, proliferation, migration, and 21 
tube formation
37
 through its recognition via ECs membrane receptors 1 and 2.
37,38
 VEGF, 22 
VEGFR-1 and VEGFR-2 are each essential for normal blood vessel development, although 23 
most of the VEGF cellular responses are mediated through the VEGFR-2, including VCAM-1 24 
and ICAM-1 expression regulation.
33
 From our results, it was observed a slighltly higher 25 
expression of VEGF and VEGFR-2 after 72 h and of VEGFR-1 after 48 h for NA-CP silanized 26 
series compared to CT (Table 2). VEGF stimulation can induce a programmed phenotypic 27 
change of ECs and become pro-thrombotic
38
 but this effect is dose dependant. An elevated 28 
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 14 
VEGF concentration can stimulate coagulation and induce EC proliferation and migration in 1 
response to trauma. Nevertheless, a minimum level is needed for the survival of the EC lining. 2 
In our case, NA-CP-RGDS and NA-CP-YIGSR surfaces presented significant higher VEGF 3 
expression compared to CT while NA-CP-RGDS+YIGSR surfaces showed the same VEGF 4 
expression as CT and physisorbed series. Nevertheless the higher expression of ICAM-1 and 5 
VCAM-1 after 72 h and 48 h respectively, onto all silanized NA-CP series independently of the 6 
immobilized peptide compared to CT indicates that the amount of VEGF expressed is low 7 
enough to maintain EC lining.  8 
The activation and propagation of the coagulation cascade is mainly prevented by ECs, which 9 
produce and secrete many anti-thrombogenic factors. Among them, endothelial nitric oxide 10 
synthetase (eNOS) which produces nitric oxide that prevents platelet aggregation and 11 
activation;
39
 and tissue type plasminogen activator (tPA) converts plasminogen into plasmin for 12 
the immediate breakdown of fibrin.
40,41
 In contrast, under pathological conditions they can 13 
secret pro-thrombogenic factors such as plasminogen activator inhibitor (PAI), which inhibits 14 
the tPA activity, and also the von Willebrand factor which activates the coagulation cascade.
38,42
 15 
The plasminogen activator inhibitor (PAI), a pro-thrombogenic factor, present a higher 16 
upregulation after 48 h onto NA-CP-YIGSR and NA-CP-RGDS+YIGSR surfaces but after 72 h 17 
the expression is reduced. Noteworthy the expression of pro-thrombogenic vWF factor 18 
decreases over time for all surfaces. This behavior is probably related to a healing process 19 
where clot formation is needed for a correct wound healing.   20 
Interestingly, the expression of anti-thrombogenic factors tPA and eNOS increased over time. 21 
The NA-CP-RGDS+YIGSR surfaces showed the higher eNOS expression compared to the 22 
other studied surfaces. The fact that the studied pro-thrombogenic genes expression decreases 23 
over time, obtaining insignificant values for PAI-1 and very low values for vWF, combined 24 
with an increase in anti-thrombogenic genes expression over time specially for functionalized 25 
series, indicate that the functionalized surfaces could promote endothelium healing and 26 
functionality and then, prevent thrombogenicity. In particular, the NA-CP-RGDS+YIGSR 27 
treatment seems to be an interesting candidate for accelerating the endothelium recovery. 28 
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 15 
Moreover, potential anti-thrombogenicity of peptides was also evaluated through platelet 1 
aggregation, by circulating human blood onto TCPS coated surfaces with RGDS, YIGSR and 2 
their combination peptides. It is well known that platelet adhesion and aggregation are mediated 3 
by fibrinogen via the receptor glycoprotein IIb/IIIa (αIIbβ3), which also recognizes the arginine-4 
glycine-aspartic (RGD) amino-acid sequence.43 Several authors have demonstrated an inhibitory 5 
effect of RGD when is present in solution.44–46 However, there are few studies concerning the 6 
effect of RGD immobilized onto surfaces on platelet adhesion and aggregation. In the present 7 
study, surprisingly, platelet adhesion was lower for RGDS peptide compared to TCPS. This 8 
reduction in platelet adhesion may be attributed to lower bond interaction between RGDS and 9 
αIIbβ3 compared to fibrinogen and αIIbβ3,
47
 which might be less stable at the applied shear 10 
stress in the present study.48 The different peptides where physisorbed to the TCPS surface, 11 
then, a low strength immobilization is expected compared to covalent bonding. This could 12 
indicate a detachment of the RGDS to the solution blocking the interaction of αIIbβ3 with 13 
fibrinogen thereby reducing the adhesion of platelets. The YIGSR and YIGSR+RGDS peptides 14 
also demonstrated lower platelet adhesion values compared to TCPS. In these cases, YIGSR 15 
non-specificity for several integrin receptors of platelet cells could be the reason for inhibiting 16 
platelet adhesion. Again, a low adhesion of the peptides to the surface could induce a 17 
detachment and then, in solution, an interaction with αIIbβ3, decreasing the number of adhered 18 
platelets.  Noteworthy, all the surfaces covered with peptides demonstrated a lower platelet 19 
aggregate size compared to TCPS. This may be attributed to the aforementioned αIIbβ3 20 
blocking capacity of the peptides used. 21 
In addition to ECs activation, communication within SMCs is an essential process for the 22 
maintenance of normal tissue physiology.13,49 The interaction between ECs and SMCs in the 23 
artery undoubtedly plays a significant role in vascular wall remodeling and and when it is 24 
inadequate could lead to the development of atherosclerotic disease and intimal hyperplasia. 25 
However, SMC proliferation at the implant surface is not desired in order to prevent restenosis. 26 
In the present work, competition between both types of cells for the modified surfaces was 27 
evaluated. At intial co-culture adhesion times, 24 h, the surfaces functionalized with NA-CP-28 
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 16 
RGDS and NA-CP-RGDS+YIGSR showed a higher number of adhered HUVECs compared to 1 
the other tested surfaces. Howere after 48 h of cell co-culture CT-YIGSR and NA-CP-2 
RGDS+YIGSR series showed the higher HUVEC adhesion. This indicates that the equimolar 3 
combination of RGDS and YIGSR immobilized onto CoCr surface, exhibit adhesion selectivity 4 
toward ECs. Therefore, an interesting synergistic effect is observed between both RGDS and 5 
YIGSR active sequences. This synergistic effect may be attributed to the fact that both RGDS 6 
and YIGSR peptides interact with different cell receptor molecules. Whereas the former is an 7 
integrin binding sequence the later interacts with the 67 kDa laminin binding protein (LBP).  It 8 
is well known that RGDS modified surfaces allow the formation of focal adhesion sites 9 
promoting cell spreading. 
50,51
 Interestingly, the YIGSR peptide has been found to co-localize 10 
LBP with α-actinin and vinculin acting as an integrin-accessory molecule that contributes to the 11 
formation of focal adhesion.
52
 In addition, activation of LBP by laminin or laminin peptides (i.e. 12 
YIGSR) has been related not only to cell attachment but also to cell differentiation, migration 13 
and capillary-like structures formation.53 Generally, functionalization increased the amount of 14 
adhered HUVEC cells onto modified CoCr surfaces compared to plain CoCr, CT, independently 15 
of the peptide used and the strategy of immobilization. Moreover, a considerably lower amont 16 
of adhered CASMCs compared to adhered HUVECs in all surfaces was found. These results are 17 
in agreement with our preliminary results of ECs and SMCs single cell culture where an 18 
enhancement of HUVEC adhesion and proliferation on the adhered biomolecules onto CoCr 19 
was found while controlling SMC adhesion.19 Herein, a higher number of ECs after 4h of 20 
culture compared to SMCs was observed. This competition for the functionalized surfaces could 21 
be critical for SMCs in co-culture conditions where ECs adhere faster probably sequestering 22 
potential SMC adhesion motifs. In addition, another possible explanation for such behavior is 23 
that both ECs and SMCs need an optimal peptide concentration for effective adhesion
54
 that is 24 
probably not achieved for satisfactory supporting SMC adhesion.  25 
 26 
CONCLUSIONS 27 
We analysed the effect of immobilizing RGDS and YIGSR peptides, and their equimolar 28 
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 17 
combination on CoCr surfaces to determine HUVECs adhesion gene expression, 1 
thrombogenicity and HUVEC/CASMC co-culture. The results suggested the positive effect of 2 
functionalized surfaces to enhace HUVECs adhesion also in co-culture with SMCs, and the 3 
decrease of thrombogenicity depending on the surface finish. Taking all together, the equimolar 4 
combination of RGDS and YIGSR seems to be the most promising strategy for 5 
endothelialization of CoCr surfaces as observed by the gene expression of genes related to 6 
adhesion, vascularization, anti-thrombogenic processes in HUVECs. Cell adhesive peptides 7 
functionalization of CoCr metallic surfaces for cardiovascular applications may offer an 8 
efficient alternative to enhance rapid endothelialization, while preventing restenosis and 9 
thrombosis.  10 
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FIGURES  LEGENDS 1 
FIGURE 1. Real time – qPCR analyses of the gene expressions for the selected genes of 2 
adhesion: a) ICAM-1 and b) VCAM-1 in HUVEC cultured on CT physisorbed and NA 3 
chemisorbed modified CoCr surfaces for 24, 48 and 72h. Results were normalized in respect to 4 
expression levels of the endogen reference gene β-actin and are represented as relative fold 5 
change to CT at 24 h (as explained in Materials and Methods section). For each studied gene, 6 
the letters a, b, c, d, e, f  join surfaces with non-significant differences (p<0.05). 7 
FIGURE 2. Real time – qPCR analyses of the gene expressions for the selected genes of 8 
vascularization: a) VEGFA, b) VEGFR-1 and c) VEGFR-2 in HUVEC cultured on CT 9 
physisorbed and NA chemisorbed modified CoCr surfaces for 24, 48 and 72h. Results were 10 
normalized in respect to expression levels of the endogen reference gene β-actin and are 11 
represented as relative fold change to CT at 24 h (as explained in Materials and Methods 12 
section). For each studied gene, the letters a, b, c, d, e, f  join surfaces with non-significant 13 
differences (p<0.05).  14 
FIGURE 3. Real time – qPCR analyses of the gene expressions for the selected genes of anti-15 
thrombogenic: a) eNOS and b) tPA in HUVEC cultured on CT physisorbed and NA 16 
chemisorbed modified CoCr surfaces for 24, 48 and 72h. Results were normalized in respect to 17 
expression levels of the endogen reference gene β-actin and are represented as relative fold 18 
change to CT at 24 h (as explained in Materials and Methods section). For each studied gene, 19 
the letters a, b, c, d join surfaces with non-significant differences (p<0.05). 20 
FIGURE 4. Real time – qPCR analyses of the gene expressions for the selected genes of pro-21 
thrombogenic: a) PAI-1 and b) vWF in HUVEC cultured on CT physisorbed and NA 22 
chemisorbed modified CoCr surfaces for 24, 48 and 72h. Results were normalized in respect to 23 
expression levels of the endogen reference gene β-actin and are represented as relative fold 24 
change to CT at 24 h (as explained in Materials and Methods section). For each studied gene, 25 
the letters a, b, c, d join surfaces with non-significant differences (p<0.05). 26 
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FIGURE 5. Platelet adhesion assay, on TCPS coated with RGDS, YIGSR and the equimolar 1 
combination RGDS+YIGSR evaluated by exposing human blood to physiological arterial shear 2 
stress. The symbols join surfaces with non-statistically significant differences (p<0.05). 3 
FIGURE 6. Overall morphology of adhered HUVEC (green) and SMC (red) cells co-cultured 4 
on a) CT phisysorbed b) NA-CP silanized biofunctionalized surfaces after 24 and 48 h and 5 
visualized by fluorescence microscopy. Bars: 50 µm. 6 
FIGURE 7. Quantification adhered HUVEC and SMC cells co-cultured on CT phisysorbed and 7 
NA-CP silanized biofunctionalized surfaces after 24 and 48 h.  8 
 9 
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Table 1. DNA sequences of forward (fw) and reverse (rv) primers for the selected genes used for real-time qPCR 
Related function 
Gene 
Symbol 
Gene title Acc. Number Primer sequences 
Amplicon 
size (bp) 
Adhesion 
ICAM-1 Intercellular adhesion molecule NM_000201.2 
fw:CCTTCCTCACCGTGTACTGG 
rv:AGCGTAGGGTAAGGTTCTTGC 
90 
VCAM-1 Vascular adhesion molecule NM_0001078.3 
fw: CATGGAATTCGAACCCAAAC     
rv: TGTATCTCTGGGGGCAACA 
70 
Vascularization 
VEGFA 
Vascular endothelial growth 
factor A 
NM_001025370.2 
fw: CCTCCGAAACCATGAACTTT      
rv: ATGATTCTGCCCTCCTCCTT 
122 
VEGFR-1 
Vascular endothelial growth 
factor receptor-1 
NM_002019.4 
fw:CAGCATACCTCACTGTTCAAGG  
rv: CCACACAGGTGCATGTTAGAG 
75 
VEGFR-2 
Vascular endothelial growth 
factor receptor-2 
NM_002253.2 
fw: CGCATCACATCCACTGGTATT  
rv: TTTGTCACTGAGACAGCTTGG 
76 
Pro-thrombogetic 
PAI-1 Plasminogen activator inhibitor NM_00062.3 
fw:AAGGCACCTCTGAGAACTTCA  
rv: CCCAGGACTAGGCAGGTG 
61 
vWF von Willebrand Factor   NM_000552.3 
fw: GAAATGTGTCAGGAGCGATG 
rv:ATCCAGGAGCTGTCCCTCA 
60 
Anti-thrombogenic 
eNOS 
Endothelial Nitric oxide-
synthetase 
NM_001160109.1 
fw: GCATCCCTACTCCCACCAG 
rv:TTCTTCACACGAGGGAACTTG 
92 
tPA Plasminogen activator NM_000930.3 
fw:AGCTGTGGGGAGCTCAGA 
rv:CACAGCGTCCCTTAAATTCAC 
105 
House keeping β-actin Beta actin NM_001101.3 
 fw: AGAGCTACGAGCTGCCTGAC 
rv: CGTGGATGCCACAGGACT 
114 
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Table 2. Summary of the gene expression analysis of CT physisorbed and NA-CP chemisorbed modified CoCr surfaces 
Time (h) 
Adhesion genes Vascularization genes Pro-thrombogenic genes Anti-thrombogenic 
ICAM-1 VCAM-1 VEGFA VEGFR-1 VEGFR-2 PAI-1 vWF tPA eNOS 
24 48 72 24 48 72 24 48 72 24 48 72 24 48 72 24 48 72 24 48 72 24 48 72 24 48 72 
CT-RGDS 
                           
CT-YIGSR 
                           
CT-RGDS+YIGSR                            
NA-CP-RGDS 
                           
NA-CP-YIGSR 
                           
NA-CP-RGDS+YIGSR 
                           
   
  Higher than CT 
  Slightly higher tan CT 
  Equal or slightly lower than CT 
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Real time – qPCR analyses of the gene expressions for the selected genes of adhesion: a) ICAM-1 and b) 
VCAM-1 in HUVEC cultured on CT physisorbed and NA chemisorbed modified CoCr surfaces for 24, 48 and 
72h. Results were normalized in respect to expression levels of the endogen reference gene β-actin and are 
represented as relative fold change to CT at 24 h (as explained in Materials and Methods section). For each 
studied gene, the letters a, b, c, d, e, f join surfaces with non-significant differences (p<0.05).  
Figure 1  
147x64mm (300 x 300 DPI)  
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Real time – qPCR analyses of the gene expressions for the selected genes of vascularization: a) VEGFA, b) 
VEGFR-1 and c) VEGFR-2 in HUVEC cultured on CT physisorbed and NA chemisorbed modified CoCr surfaces 
for 24, 48 and 72h. Results were normalized in respect to expression levels of the endogen reference gene 
β-actin and are represented as relative fold change to CT at 24 h (as explained in Materials and Methods 
section). For each studied gene, the letters a, b, c, d, e, f join surfaces with non-significant differences 
(p<0.05).  
Figure 2  
205x124mm (300 x 300 DPI)  
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Real time – qPCR analyses of the gene expressions for the selected genes of anti-thrombogenic: a) eNOS 
and b) tPA in HUVEC cultured on CT physisorbed and NA chemisorbed modified CoCr surfaces for 24, 48 and 
72h. Results were normalized in respect to expression levels of the endogen reference gene β-actin and are 
represented as relative fold change to CT at 24 h (as explained in Materials and Methods section). For each 
studied gene, the letters a, b, c, d join surfaces with non-significant differences (p<0.05).  
Figure 3  
140x58mm (300 x 300 DPI)  
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Real time – qPCR analyses of the gene expressions for the selected genes of pro-thrombogenic: a) PAI-1 
and b) vWF in HUVEC cultured on CT physisorbed and NA chemisorbed modified CoCr surfaces for 24, 48 
and 72h. Results were normalized in respect to expression levels of the endogen reference gene β-actin and 
are represented as relative fold change to CT at 24 h (as explained in Materials and Methods section). For 
each studied gene, the letters a, b, c, d join surfaces with non-significant differences (p<0.05).  
Figure 4  
175x75mm (300 x 300 DPI)  
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Platelet adhesion assay, on TCPS coated with RGDS, YIGSR and the equimolar combination RGDS+YIGSR 
evaluated by exposing human blood to physiological arterial shear stress. The symbols join surfaces with 
non-statistically significant differences (p<0.05).  
Figure 5  
118x36mm (300 x 300 DPI)  
 
 
Page 32 of 34
John Wiley & Sons, Inc.
Journal of Biomedical Materials Research: Part A
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
  
 
 
Overall morphology of adhered HUVEC (green) and SMC (red) cells co-cultured on a) CT phisysorbed b) NA-
CP silanized biofunctionalized surfaces after 24 and 48 h and visualized by fluorescence microscopy. Bars: 
50 µm.  
Figure 6  
165x122mm (300 x 300 DPI)  
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Quantification adhered HUVEC and SMC cells co-cultured on CT phisysorbed and NA-CP silanized 
biofunctionalized surfaces after 24 and 48 h.  
Figure 7  
147x72mm (300 x 300 DPI)  
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